LifeMD Inc. Common Stock (LFMD)

About LFMD

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss…

Sector

Health Care

Industry

Medical/Nursing Services

Employees

347

Website

lifemd.com/

Fundamentals

1-day range

$3.14$3.3

Market cap

$164.43M

P/E (trailing)

829.68

P/E (forward)

8.26

EPS (trailing)

$0.01

Dividend yield

—

Beta

1.94

Avg. volume

934.5K

Dividend pay date

October 14, 2020

Forecasts

8 analyst ratings

LifeMD Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• LFMD

  LifeMD Inc. Common Stock

  $3.14

  ▼ 3.68%
  Market cap $164.43MP/E 829.68
  $2.56$7.32
• NAKA

  Nakamoto Inc. Common Stock

  $7.41

  ▼ 4.14%
  Market cap $86.14MP/E —
• PIII

  P3 Health Partners Inc. Class A Common Stock

  $9.22

  ▼ 2.95%
  Market cap $78.90MP/E —
  $1.52$16.89
• ALPS

  ALPS Group Inc Ordinary Share

  $0.385

  ▼ 0.47%
  Market cap $69.06MP/E —
  $0.2293$15
• EUDA

  EUDA Health Holdings Limited Ordinary Shares

  $14.61

  ▼ 2.76%
  Market cap $48.78MP/E —
  $5.26$86
• ATPC

  Agape ATP Corporation Common Stock

  $2.39

  ▲ 0.84%
  Market cap $2.49MP/E —
  $1.72$73.5
• PIIIW

  P3 Health Partners Inc. Warrant

  $0.0129

  ▲ 7.50%
  Market cap $122.4KP/E —
  $0.0011$0.25

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• LifeMD: What The Bulls Got Wrong
  SeekingAlpha · 8/20/2026
• LifeMD, Inc. 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/11/2026
• HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $9
  Benzinga · 8/7/2026
• B. Riley Securities Maintains Buy on LifeMD, Lowers Price Target to $8
  Benzinga · 8/6/2026
• LifeMD, Inc. (LFMD) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/6/2026
• BTIG Maintains Buy on LifeMD, Lowers Price Target to $9
  Benzinga · 8/6/2026
• LifeMD (NASDAQ:LFMD) Shares Slide After Q2 Revenue and EPS Miss
  ChartMill · 8/6/2026
• LifeMD Lowers FY2026 Sales Guidance from $220.000M-$230.000M to $205.500M-$212.500M vs $222.046M Est
  Benzinga · 8/5/2026

• Calum Archibald MacRae · August 11, 2026 · Grant

  35.0K
• Joseph DiTrolio · August 11, 2026 · Grant

  35.0K
• Roberto Simon · August 11, 2026 · Grant

  35.0K
• Umesh Sripad · June 1, 2026 · Grant

  75.0K
• Atul Kavthekar · May 11, 2026 · Grant

  337.5K
• Roberto Simon · May 4, 2026 · Grant

  50.0K
• Christopher A. Pisano · March 30, 2026 · Grant

  200.0K

Institutional Ownership

March 31, 2026

Total shares held

17.75M

Total value held

$63.76M

Institutional holders

99